Agency Information Collection Activities; Announcement of Office of Management and Budget Approval; Guidance for Industry and Food and Drug Administration Staff-Class II Special Controls Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle

Riepilogo

The Food and Drug Administration (FDA) is announcing that a collection of information entitled "Guidance for Industry and Food and Drug Administration Staff--Class II Special Controls Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle" has been approved by the Office of Management and Budget (OMB) under the Paperwork Reduction Act of 1995.